Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
about
Safety and efficacy evaluation of pertuzumab in patients with solid tumorsDental Application of Natural Products.Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.Lung, CNS and musculo-skeletal targeted therapy-induced toxicity: imaging features.
P2860
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
@ast
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
@en
type
label
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
@ast
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
@en
prefLabel
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
@ast
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
@en
P2093
P2860
P356
P1476
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents
@en
P2093
J S de Bono
J Vitfell Pedersen
L R Molife
M Blanco Codesido
P2860
P2888
P304
P356
10.1038/BJC.2012.482
P407
P50
P577
2012-10-25T00:00:00Z